Molecular diagnosis of human granulocytic anaplasmosis

Expert Review of Molecular Diagnostics
J S Dumler, P Brouqui

Abstract

Human granulocytic anaplasmosis, formerly known as human granulocytic ehrlichiosis, is caused by the microorganism Anaplasma phagocytophilum that is transmitted by Ixodes tick bites. The disease state ranges from subclinical to fatal but may be difficult to differentiate from other febrile conditions without specific tests. Rapid and early diagnosis is important since the infection may be fatal and specific antibiotic therapy is required. The bacterium is an obligate intracellular pathogen of neutrophils. Thus, early diagnosis is best achieved by amplification of nucleic acids from the blood. An increasing number of potential gene targets for diagnostic assays have been described and the incipient release of an Anaplasma phagocytophilum genome sequence will not only help to better understand the disease but may facilitate improvements in diagnostic strategies.

References

Apr 2, 1987·The New England Journal of Medicine·K MaedaJ E McDade
Oct 1, 1995·The Journal of Infectious Diseases·P PancholiD H Persing
Mar 1, 1994·Journal of Clinical Microbiology·S M ChenD H Walker
Jan 25, 1996·The New England Journal of Medicine·J L GoodmanU G Munderloh
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·S R TelfordD H Persing
Dec 1, 1996·Annals of Internal Medicine·M E Aguero-RosenfeldJ S Dumler
Apr 1, 1997·Journal of Clinical Microbiology·M T YehR F Massung
Jun 1, 1997·Journal of Clinical Microbiology·M PetrovecJ S Dumler
Jun 13, 1998·The Journal of Clinical Investigation·P WebsterE Fikrig
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M I BuitragoF J Bia
Jul 15, 1999·The New England Journal of Medicine·R S BullerG A Storch
Oct 8, 1999·Emerging Infectious Diseases·J H McQuistonJ E Childs
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S Bakken, J S Dumler
Jan 4, 2001·Clinical and Diagnostic Laboratory Immunology·P BrouquiD Raoult
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·H W HorowitzJ M Wu
Mar 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S BakkenJ S Dumler
Jul 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P J MolloyV P Berardi
Aug 31, 2001·Clinical and Diagnostic Laboratory Immunology·S Lotric-FurlanF Strle
Nov 29, 2001·Journal of Clinical Microbiology·M ArnezF Strle
Feb 8, 2003·Journal of Clinical Microbiology·Robert F Massung, Kimetha G Slater
Jul 16, 2003·Annals of the New York Academy of Sciences·Joshua W Courtney, Robert F Massung

❮ Previous
Next ❯

Citations

Jan 6, 2012·Vector Borne and Zoonotic Diseases·Hongtao JinJun Qian
Feb 11, 2012·Diagnostic Microbiology and Infectious Disease·Christelle KoebelSylvie Josiane De Martino
Jan 11, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Florence Fenollar, Didier Raoult
Apr 29, 2015·Transboundary and Emerging Diseases·H Ait LbachaR Maillard
Apr 15, 2015·The American Journal of Tropical Medicine and Hygiene·F Scott DahlgrenCasey Barton Behravesh
Aug 3, 2012·The American Journal of Tropical Medicine and Hygiene·Nalika De SilvaJohn Stenos
May 24, 2018·BMC Veterinary Research·I I ShabanaH Zaraket
May 3, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah E TurbettJohn A Branda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Emerging Infectious Diseases
Lin ZhanJ Dik F Habbema
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Johan S Bakken, J S Dumler
Veterinary Research Communications
A Torina, S Caracappa
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
V RemyP Brouqui
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J S DumlerJohan S Bakken
© 2022 Meta ULC. All rights reserved